CIT-013 high dose

DRUG3 trials

Sponsors

Citryll BV

Conditions

Healthy AdultHidradenitis Suppurativa (HS)Rheumatoid Arthritis

Phase 1

Phase 1 Trial to Evaluate 150 mg Subcutaneous CIT-013

Not yet recruitingNCT07499908

Citryll BVHealthy Adult

Start: 2026-05-31End: 2026-10-31Target: 10Updated: 2026-04-13

Phase 2

A Study With CIT-013 in RA Patients

RecruitingNCT06567470

Citryll BVRheumatoid Arthritis

Start: 2025-07-29End: 2027-07-01Target: 88Updated: 2026-05-22

A Study With CIT-013 in HS Patients

RecruitingNCT06993233

Citryll BVHidradenitis Suppurativa (HS)

Start: 2025-10-31End: 2027-07-01Target: 96Updated: 2026-05-22